312 related articles for article (PubMed ID: 26062929)
1. The influence of low-grade inflammation on platelets in patients with stable coronary artery disease.
Larsen SB; Grove EL; Würtz M; Neergaard-Petersen S; Hvas AM; Kristensen SD
Thromb Haemost; 2015 Aug; 114(3):519-29. PubMed ID: 26062929
[TBL] [Abstract][Full Text] [Related]
2. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
3. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
Müller KA; Chatterjee M; Rath D; Geisler T
Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
[TBL] [Abstract][Full Text] [Related]
4. Platelets, inflammation and anti-inflammatory drugs in ACS and CAD.
Schrör K; Huber K
Thromb Haemost; 2015 Aug; 114(3):446-8. PubMed ID: 26288949
[No Abstract] [Full Text] [Related]
5. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
[TBL] [Abstract][Full Text] [Related]
6. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
7. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease.
Meyer A; Weithaeuser A; Steffens D; Bobbert P; Hassanein A; Ayral Y; Schultheiss HP; Rauch U
Cardiovasc Revasc Med; 2016; 17(3):169-75. PubMed ID: 27157293
[TBL] [Abstract][Full Text] [Related]
9. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid.
Verdoia M; Schaffer A; Pergolini P; Rolla R; Barbieri L; Bellomo G; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
J Cardiovasc Pharmacol; 2015 Jul; 66(1):35-40. PubMed ID: 25714593
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
Schrottmaier WC; Kral JB; Badrnya S; Assinger A
Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
[TBL] [Abstract][Full Text] [Related]
14. Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation.
Larsen SB; Grove EL; Hvas AM; Kristensen SD
PLoS One; 2014; 9(1):e85566. PubMed ID: 24465602
[TBL] [Abstract][Full Text] [Related]
15. Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease.
Akboga MK; Canpolat U; Yayla C; Ozcan F; Ozeke O; Topaloglu S; Aras D
Angiology; 2016 Jan; 67(1):89-95. PubMed ID: 25922197
[TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.
Lee BJ; Lin JS; Lin YC; Lin PT
Nutrition; 2015 Mar; 31(3):475-9. PubMed ID: 25701337
[TBL] [Abstract][Full Text] [Related]
17. Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
Chatterjee M; Behrendt A; Schmid M; Beck S; Schneider M; Mack A; Müller I; Geisler T; Gawaz M
Thromb Haemost; 2017 Jan; 117(2):311-324. PubMed ID: 27929199
[TBL] [Abstract][Full Text] [Related]
18. Aspirin in coronary artery disease: an appraisal of functions and limitations.
Würtz M
Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions?
Hohlfeld T; Schrör K
Thromb Haemost; 2015 Aug; 114(3):469-77. PubMed ID: 26085050
[TBL] [Abstract][Full Text] [Related]
20. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
